Use of ID4 for diagnosis and treatment of cancer

Details for Australian Patent Application No. 2010232499 (hide)

Owner John Wayne Cancer Institute

Inventors Hoon, Dave S. B.; Umetani, Naoyuki

Agent Spruson & Ferguson

Pub. Number AU-A-2010232499

PCT Pub. Number WO2010/115127

Priority 12/417,577 02.04.09 US

Filing date 2 April 2010

Wipo publication date 7 October 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

20 January 2011 PCT application entered the National Phase

  PCT publication WO2010/115127 Priority application(s): WO2010/115127

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010232503-Non-aqueous dentifrice composition with bioacceptable and bioactive glass and methods of use and manufacture thereof

2010232497-Composition of 2,4,6-trifluoro-N-[6-(1-methyl-piperidin-4 -carbonyl)-pyridin-2-yl]-benzamide